Roei D. Mazor

TRAF3 suppression encourages B cell recruitment and prolongs survival of microbiome-intact mice with ovarian cancer

M. Elkabets, J. Moran-Gilad, Y. Motro, 2023, bioRxiv.

Tumor-reactive antibodies evolve from non-binding and autoreactive precursors

M. Feinmesser, I. Zaretsky, J. Gershoni, 2022, Cell.

Clinical phenotypes and long-term outcome of kidney involvement in Erdheim-Chester histiocytosis.

A. Vaglio, Z. Amoura, H. Izzedine, 2022, Kidney international.

Erdheim-Chester disease: Consensus recommendations for the evaluation, diagnosis, and treatment in the molecular era.

A. Goodman, F. Janku, E. Jacobsen, 2020, Blood.